Even though lower price cards can assist relieve the load of substantial drug expenditures from the temporary, they do not tackle the systemic problems driving up prescription costs during the U.S. Broader coverage adjustments could deal with the foundation leads to of climbing drug selling prices, for instance insufficient transparency in pricing